{
    "nctId": "NCT05122585",
    "briefTitle": "Magnetic Tracer in the Sentinel Node Procedure in Breast Cancer: the Non-radioactive Alternative for Radio-isotopes",
    "officialTitle": "Magnetic Tracer in the Sentinel Node Procedure in Breast Cancer: the Non-radioactive Alternative for Radio-isotopes",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "The concordance in detection of sentinel nodes by Magtrace and the Technetium tracer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patient of 18 years or older.\n* Patient with breast cancer and indication for sentinel node procedure.\n\nExclusion Criteria:\n\n* Patients with a previous history of the sentinel node procedure or axillary lymph node dissection in the unilateral breast.\n* Unable to comprehend implications and extent of study and sign for informed consent.\n* Known allergy or hypersensitivity to iron oxide or dextran.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}